Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.